Acceptability of levofloxacin, moxifloxacin and linezolid among children and adolescents treated for TB

Int J Tuberc Lung Dis. 2020 Dec 1;24(12):1316-1318. doi: 10.5588/ijtld.20.0544.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents*
  • Aza Compounds
  • Child
  • Fluoroquinolones
  • Humans
  • Levofloxacin*
  • Linezolid*
  • Microbial Sensitivity Tests
  • Moxifloxacin*
  • Ofloxacin
  • Tuberculosis* / drug therapy

Substances

  • Anti-Bacterial Agents
  • Aza Compounds
  • Fluoroquinolones
  • Levofloxacin
  • Linezolid
  • Moxifloxacin
  • Ofloxacin